When a nerve impulse arrives at a 5-HT or noradrenaline nerve terminal the neurotransmitter is released from the synaptic vesicle into the synaptic cleft. Neurotransmitter molecules bind to their specific receptors on the post-synaptic membrane and the nerve impulse is propagated or inhibited, depending on the receptor type. 5-HT and noradrenaline molecules are then released from their receptors and taken back into the nerve terminal via either the 5-HT or noradrenaline re-uptake transporters. 5-HT and noradrenaline are degraded by monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT), these enzymes are found in the nerve terminal.1,2

Click here: Learn about the normal processes of serotonin and noradrenaline synaptic activity

file_download Download in HQ

Related content

image Image Stroke, migraine, AD and other dementias were among the top ten conditions that accounted for the greatest nervous system DALYs in 2021
Highlights from the Global Burden of Disease 2021 Study

Stroke, migraine, Alzheimer’s Disease and other dementias were among the top ten conditions that accounted for the greatest nervous system DALYs in 2021

25.07.2024 Alzheimer’s Disease
image Image
The progression of addictive disorders over time

An illustration of the progression of addictive disorders over time.

24.07.2024 Substance Use Disorders
description Article
Global perspectives on Alzheimer’s disease diagnosis and treatment: challenges and considerations in resource-limited settings

Alzheimer’s disease (AD) is the most prevalent neurodegenerative disease and the leading cause of dementia worldwide, regardless of socioeconomic status.

09.07.2024 Alzheimer’s Disease